GlassScriptPhysician profile
Stephen T Crowley
NPI 1194711994
$8,345.35
in general payments reported to CMS, 2019-2025
36 companies · $760 in 2025
The $760 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,165 · 2020: $725 · 2021: $1,165 · 2022: $1,027 · 2023: $900 · 2024: $1,603 · 2025: $760.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,263.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,263.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shockwave Medical, INC | $1,517.47 | 2021-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Medtronic Vascular, INC. | $1,211.63 | 2019-2020 | |
| Medtronic, INC. | $1,203.11 | 2021-2024 | Corevalve Evolut R, Symplicity G3, Onyx Frontier |
| Boston Scientific Corporation | $887.44 | 2019-2023 | Watchman Access System |
| Biotronik INC. | $647.78 | 2019-2022 | |
| Philips North America LLC | $467.98 | 2019-2024 | (9266) Elca, (P84) Igt Devices Systems |
| Abiomed | $282.07 | 2019-2025 | Impella |
| Pfizer INC. | $209.18 | 2019-2025 | |
| Amgen INC. | $188.42 | 2019-2025 | Repatha |
| Novartis Pharmaceuticals Corporation | $183.21 | 2024 | |
| Cvrx, INC. | $177.40 | 2023-2024 | Barostim Neo System |
| Abbott Laboratories | $149.42 | 2020-2022 | |
| E.R. Squibb & Sons, L.L.C. | $148.47 | 2019-2025 | Eliquis, Camzyos |
| Edwards Lifesciences Corporation | $147.36 | 2020-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Heartflow, INC. | $137.38 | 2024 |
Show all 36 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Crowley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.